PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States with the potential of breaking out.
Beverly Hills, CA -- (SBWIRE) -- 01/11/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: TELK, DNDN, and VELT
The market pulled back from its 5 year high on Friday trading mixed with the S&P 500 falling two points to 1,470 as of 1:18 p.m. Eastern. It closed at 1,472 Thursday, its highest level since December 2007. The Dow Jones industrial average rose fell a point to 13,470. The Nasdaq composite index dropped two points to 3,119.
1. Telik (NASDAQ:TELK) - Telik, Inc. is a biopharmaceutical company focused on the discovery and development of small-molecule biopharmaceuticals for itself and its partners.
2. Dendreon Corp. (NASDAQ:DNDN) - Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer.
3. Velti Plc (NASDAQ:VELT) - Velti plc provides marketing and advertising technology that enable brands, advertising agencies, mobile operators and media companies to implement targeted, interactive and measurable campaigns via mobile devices.
Pennystocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com
Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.
Pennystocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)